aTyr Pharma, Inc. (ATYR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 67.58M | 80.24M | 93.01M | 87.49M | 83.27M | 81.95M | 76.32M | 90.3M | 96.92M | 102.99M | 107.3M | 114.43M |
| Cash & Short-Term Investments | 66.51M | 78.69M | 90.2M | 80.35M | 76.35M | 72.13M | 65.99M | 78.48M | 84.5M | 98.17M | 102.13M | 108.58M |
| Cash Only | 10.01M | 10.74M | 6.15M | 17.22M | 10.36M | 11.05M | 11.46M | 6.8M | 6.81M | 22.54M | 9.79M | 12.31M |
| Short-Term Investments | 56.51M | 67.94M | 84.05M | 63.13M | 65.99M | 61.07M | 54.53M | 71.68M | 77.69M | 75.62M | 92.34M | 96.27M |
| Accounts Receivable | 477K | 873K | 1.04M | 498K | 988K | 1.74M | 1.83M | 1.63M | 2.48M | 2.44M | 2.09M | 1.29M |
| Days Sales Outstanding | - | - | 372.84 | - | - | - | - | - | 951.05 | - | 439.67 | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 12.08M | 13.93M | 13.64M | 14.04M | 13.97M | 14.88M | 15.3M | 15.64M | 16.34M | 17.66M | 17.77M | 18.32M |
| Property, Plant & Equipment | 10.13M | 10.38M | 10.78M | 11.1M | 11.48M | 11.86M | 12.24M | 12.62M | 12.99M | 14.05M | 14.25M | 14.82M |
| Fixed Asset Turnover | - | - | 0.02x | - | - | - | - | - | 0.02x | - | 0.02x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 1.8M | 2.23M | 2.71M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.42M |
| Other Non-Current Assets | 148K | 1.31M | 149K | 2.94M | 2.5M | 3.02M | 3.06M | 3.03M | 3.34M | 3.62M | 3.52M | 72K |
| Total Assets | 79.65M | 94.16M | 106.65M | 101.53M | 97.25M | 96.83M | 91.62M | 105.94M | 113.25M | 120.65M | 125.07M | 132.75M |
| Asset Turnover | - | - | 0.00x | - | - | - | - | - | 0.00x | - | 0.00x | - |
| Asset Growth % | -18.09% | -2.75% | 16.41% | -4.16% | -14.13% | -19.75% | -26.75% | -20.19% | -17.24% | 25.96% | 30.21% | 38.26% |
| Total Current Liabilities | 11.7M | 15.15M | 15.68M | 15.53M | 10.68M | 14.97M | 14.12M | 11.84M | 15.98M | 16.42M | 12.88M | 12.37M |
| Accounts Payable | 2.75M | 3.89M | 4.06M | 3.88M | 1.53M | 4.32M | 3.95M | 1.25M | 4.89M | 3.53M | 2.04M | 516K |
| Days Payables Outstanding | 759.06 | - | 16.51 | - | - | 31.12 | - | - | - | 629.76 | 118.54 | 347.93 |
| Short-Term Debt | 1.49M | 1.47M | 1.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 7.46M | 9.79M | 10.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 5.78x | 5.30x | 5.93x | 5.63x | 7.79x | 5.48x | 5.41x | 7.63x | 6.07x | 6.27x | 8.33x | 9.25x |
| Quick Ratio | 5.78x | 5.30x | 5.93x | 5.63x | 7.79x | 5.48x | 5.41x | 7.63x | 6.07x | 6.27x | 8.33x | 9.25x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 10.21M | 11.73M | 10.93M | 11.35M | 11.7M | 12.03M | 12.36M | 12.68M | 12.99M | 13.77M | 13.98M | 14.33M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 10.21M | 10.57M | 10.93M | 11.35M | 11.7M | 12.03M | 12.36M | 12.68M | 12.99M | 13.77M | 13.98M | 14.33M |
| Deferred Tax Liabilities | 0 | 1.16M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 21.91M | 26.88M | 26.61M | 26.88M | 22.38M | 27M | 26.48M | 24.52M | 28.97M | 30.18M | 26.87M | 26.7M |
| Total Debt | 11.7M | 12.03M | 12.36M | 12.68M | 12.99M | 13.28M | 13.57M | 13.85M | 14.13M | 15.1M | 15.22M | 15.39M |
| Net Debt | 1.69M | 1.29M | 6.21M | -4.54M | 2.63M | 2.23M | 2.11M | 7.05M | 7.32M | -7.45M | 5.43M | 3.08M |
| Debt / Equity | 0.20x | 0.18x | 0.15x | 0.17x | 0.17x | 0.19x | 0.21x | 0.17x | 0.17x | 0.17x | 0.15x | 0.15x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 57.74M | 67.29M | 80.04M | 74.66M | 74.86M | 69.83M | 65.14M | 81.42M | 84.28M | 90.47M | 98.2M | 106.05M |
| Equity Growth % | -22.87% | -3.64% | 22.88% | -8.31% | -11.18% | -22.81% | -33.67% | -23.22% | -23.17% | 26.91% | 27.53% | 22.66% |
| Book Value per Share | 0.59 | 0.69 | 0.82 | 0.83 | 0.87 | 0.84 | 0.86 | 1.13 | 1.28 | 1.53 | 1.70 | 1.92 |
| Total Shareholders' Equity | 57.93M | 67.48M | 80.23M | 74.84M | 75.05M | 70.02M | 65.33M | 81.61M | 84.47M | 90.66M | 98.39M | 106.24M |
| Common Stock | 98K | 98K | 98K | 93K | 89K | 84K | 76K | 76K | 68K | 63K | 59K | 57K |
| Retained Earnings | -616.96M | -606.16M | -592.2M | -566.46M | -546.93M | -532.05M | -517.08M | -499.82M | -483.51M | -468.02M | -453.26M | -441.92M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -70K | -8K | -1K | -75K | -66K | -40K | 36K | -168K | -158K | -74K | -294K | -333K |
| Minority Interest | -193K | -192K | -191K | -189K | -188K | -187K | -186K | -184K | -184K | -188K | -187K | -185K |